Physician profile
Cynthia A Wait
NPI 1447252804
$2,209.14
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $334 · 2021: $47.64.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $660.00 | 2019 | |
| Janssen Scientific Affairs, LLC | $229.17 | 2019 | |
| Abbvie INC. | $217.31 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.99 | 2019-2020 | |
| Qol Medical, LLC | $151.92 | 2019-2020 | |
| Janssen Biotech, INC. | $143.67 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.83 | 2019-2020 | |
| Harmony Biosciences LLC | $112.49 | 2020 | |
| Gilead Sciences, INC. | $106.95 | 2019-2021 | |
| Pfizer INC. | $89.74 | 2019-2021 | |
| Ucb, INC. | $64.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.07 | 2019-2020 | |
| Shionogi INC | $38.39 | 2019 | |
| Romark Laboratories, Lc | $13.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Wait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.